Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Future of PDSG?

As of May 31, 2011 and 2010, our backlog is $834,485 and $268,103, respectively, which consists of revenues from contracts executed with customers which have yet to be recognized as of the applicable fiscal years then ended

.

.

.

Be well

Share
New Message
Please login to post a reply